Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel ; volume:15 ; number:1 ; day:29 ; month:6 ; year:2017 ; pages:1-9 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (29.6.2017), 1-9, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Pires-Luís, Ana Sílvia
- Contributor
-
Costa-Pinheiro, Pedro
Ferreira, Maria João
Antunes, Luis
Lobo, Francisco
Oliveira, Jorge
Henrique, Rui
Jerónimo, Carmen
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1248-y
- URN
-
urn:nbn:de:1111-2017092311135
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pires-Luís, Ana Sílvia
- Costa-Pinheiro, Pedro
- Ferreira, Maria João
- Antunes, Luis
- Lobo, Francisco
- Oliveira, Jorge
- Henrique, Rui
- Jerónimo, Carmen
- SpringerLink (Online service)
Other Objects (12)
Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma
Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma
Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
Methylation Status of the Nanog Promoter Determines the Switch between Cancer Cells and Cancer Stem Cells
Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma
Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma
Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
Methylation Status of the Nanog Promoter Determines the Switch between Cancer Cells and Cancer Stem Cells
Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma
Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells
Promoter methylation signatures in relapsed pediatric T-cell acute lymphoblastic leukemia
Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma
Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation